What was the purpose of this study?
The main questions the researchers wanted to answer in this study were:
X What signs and symptoms did the participants have during the study?
X What medical problems did the participants have during the study?
The answers to these questions are important to know before other studies can be
done to find out if MEDI5083 and durvalumab help improve the health of people
with advanced solid tumors.
3 | Clinical Study Results